Rgenta Therapeutics Funding: $90M Raised, Series A (2022)
Rgenta Therapeutics is based in Woburn, MA. It has raised $90M in total funding. Latest round: Series A.
Rgenta Therapeutics funding overview
Rgenta Therapeutics is based in Woburn, MA. Rgenta Therapeutics has raised $90M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2022. The round record for Rgenta Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Boehringer Ingelheim Venture Fund, Matrix Partners China, Vivo Capital, Chen Bing, Delos Capital, Korea Investment Partners and 4 others. 10 distinct backers are named across the disclosed rounds.
Rgenta Therapeutics at a glance
Total raised
$90M
Latest round
Series A
Latest round date
November 2022
Headquarters
Woburn, MA
Notable investors
Boehringer Ingelheim Venture Fund, Matrix Partners China, Vivo Capital, Chen Bing, Delos Capital, Korea Investment Partners, Judith Li, ALSA Ventures
Frequently asked about Rgenta Therapeutics funding
How much has Rgenta Therapeutics raised?
Rgenta Therapeutics has raised $90M in total disclosed funding across the rounds on record.
Who has invested in Rgenta Therapeutics?
Boehringer Ingelheim Venture Fund, Matrix Partners China, Vivo Capital, Chen Bing, Delos Capital, Korea Investment Partners are named among the investors backing Rgenta Therapeutics.
What was the latest Rgenta Therapeutics funding round?
The most recent disclosed round is a Series A, announced in November 2022.
Where is Rgenta Therapeutics based?
Rgenta Therapeutics is based in Woburn, MA.
When did Rgenta Therapeutics last raise?
The last disclosed Rgenta Therapeutics round closed in November 2022 at Series A.
We update the Rgenta Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Woburn and their backers are listed below.
